Skip to main content
Clinical Trials/NCT03453463
NCT03453463CompletedNot Applicable

Impact of Exercise on Sarco-osteopenia in Community Dwelling Men 70 Years and Older. A Randomized Controlled Trial

University of Erlangen-Nürnberg Medical School2 sites in 1 country43 target enrollmentStarted: January 15, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
43
Locations
2
Primary Endpoint
Lumbar spine Bone Mineral Density (QCT)

Study Overview

Brief Summary

The study determined the effects of predominately resistance type exercise in combination with protein supplements on parameters of sarcopenia and osteopenia (sarco-osteopenia) in older, community dwelling men with sarcopenia and -osteopenia over 18 months.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Masking Description

Outcome assessor are not aware of participant status and are nor allowed to ask correspondingly

Eligibility Criteria

Ages
70 Years to — (Older Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Sarcopenia according to Baumgartner et al.(SMI: > -2 SD* T-Score)
  • Osteopenia at the lumbar spine or hip according to WHO (> -1 SD T-Score)
  • community dwelling people
  • able to transfer to our lab

Exclusion Criteria

  • secondary osteoporosis
  • history of hip fracture
  • medication/diseases that relevantly affect muscle/bone metabolism (last 2 years)
  • alcohol abuses of more than 60 g/d ethanol
  • cardio-vascular diseases that prevent exercise
  • very low physical capacity that prevent exercise in a group setting
  • SD: Standard Deviation

Outcomes

Primary Outcomes

Lumbar spine Bone Mineral Density (QCT)

Time Frame: changes from baseline to 18 months

Lumbar spine Bone Mineral Density as determined by Quantitative Computed Tomography

Secondary Outcomes

  • Lumbar spine Bone Mineral Density (DXA)(changes from baseline to 12 and 18 months)
  • Skeletal muscle mass index(changes from baseline to 6, 12 and 18 months)
  • Hip and leg extensor strength(changes from baseline to 6, 12 and 18 months)
  • Gait velocity(changes from baseline to 6, 12 and 18 months)
  • Hand-grip strength(changes from baseline to 6, 12 and 18 months)
  • Femoral Neck Bone Mineral Density(changes from baseline to 12 and 18 months)
  • Muscle Density at the calf, thigh and para-vertebral site(changes from baseline to 6 and 12 months)

Investigators

Sponsor
University of Erlangen-Nürnberg Medical School
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Exercise Effects on Sarco-Osteopenia in... | Clinical Trial